Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Midatech Pharma
Midatech Pharma
Activities:
Drug Delivery
X
LinkedIn
Trending Articles
Optimising RNA production for faster and cheaper pharmaceutical manufacturing
RNA production can be a lengthy and complex process, but the Ntensify platform could change this by diminishing development times, decreasing production costs and allowing the...
ChargePoint invest in a single-use manufacturing facility to expand product line
The single-use manufacturing facility will become fully operational in June 2024, and will support the company's trio of liquid and powder transfer devices
Memel Biotech and Therabest collaborate to develop exosome-based cell therapies
The partnership will aim to develop, manufacture and distribute novel exosome cell therapies in a range of therapeutic areas
Owlstone Medical bags $6.5m to optimise infectious disease diagnostic tool
The Bill & Melinda Gates Foundation has funded the bolstering of the Breath Biopsy platform, as well as research into breath biomarkers in tuberculosis (TB) and HIV
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Research & Development
Nanofacturing consortium makes significant progress
Partners across Europe collaborate to establish a pilot line for the scale-up and production of nanopharmaceutical products
Research & Development
Midatech Pharma-led consortium wins €7.9m in funding
For project to scale-up manufacturing of gold nanoparticle-based therapeutics for diabetes and rare cancers
Research & Development
Midatech appoints Nick Robbins-Cherry as Finance Director
Strengthening the senior management team at the nanomedicines specialist
Research & Development
Midatech makes two appointments
Strengthening the Board and senior management team
You need to be a subscriber to read this article.
Click here
to find out more.
Drug Delivery
Helping the delivery of biotech-based therapies
Modern biotech-derived medicines require new methods to aid targeted delivery. Dr Sarah Houlton, looks at some of the novel nano-based technologies that are getting results
Drug Delivery
Midatech raises £10m to advance gold-nanoparticle technology
For diabetes and cancer treatment and to work to commercialise new applications in medical diagnostics and imaging
Research & Development
MidaSol Therapeutics signs research collaboration with major US pharmaceutical company
Midatech and MonoSol Rx joint venture to develop new treatment for diabetes
Subscribe now